Ozempic, Wegovy Shortage Is Officially Over
The shortage of semaglutide injections (Ozempic, Wegovy) is over, the FDA announced on Friday. The agency, along with maker Novo Nordisk, confirmed that supply now meets or exceeds both the current and projected U.S. demand. The injectable formulation of the GLP-1 receptor agonist has been in shortage since August 2022 due to increased demand.
The resolution could potentially restrict how telehealth programs offer cheaper versions known as compounded drugs ...
Weight loss injections have become incredibly popular in the last year or so. In fact, these medications are so widely used ...
Shares of Novo Nordisk (NVO) are up 6% in pre-market trading after a FDA drug shortage notice indicated that a shortage of several versions of ...
Two Omaha women lost more than 300 lbs. combined with injections of a GLP-1 drug, which are used increasingly for weight loss ...
Local companies are developing technologies that they hope could replace a painful poke with something that feels more like ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback